Sort
130,381 grants matching “hiv”
Effectiveness of the HPV Vaccine in Immunocompromised Populations
$827,605Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2025 · AI
Interplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assembly
$827,566Cynthia Ann Derdeyn · University Of Washington · R01 · FY2023 · AI
Modulation of Galectin-9 to Target HIV Persistence
$827,545Satish Kumar Pillai · Vitalant · R01 · FY2025 · AI
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
$827,529Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HG
Parental Involvement, Extra-Familial Contexts and Prevention of Drug Use Risk.
$827,522Daniel S Shaw · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · DA
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$827,515Craig R Cohen · University Of California, San Francisco · R01 · FY2022 · HD
Inhibitors and Probes of HIV-1 Cell Fusion
$827,494Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Inhibitors and Probes of HIV-1 Cell Fusion
$827,493Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Impact of HIV Envelope Conformation on Immunogenicity
$827,465Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2011 · AI
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
$827,457R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$827,328Afamefuna Okoye · Oregon Health & Science University · R01 · FY2024 · AI
Envelope Glycoprotein Incorporation and Function
$827,285Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
HIV-1 Gag Assembly and Maturation
$827,285Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
B cell determinants of EBV latency
$827,278Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2024 · CA
NHP Core for Development of an Integrase Defective Lentiviral Vector HIV Vaccine
$827,260Sampa Santra · Duke University · P01 · FY2015 · AI
STRUCTURES OF HIV REVERSE TRANSCRIPTASE WITH SUBSTRATES
$827,252Rutgers The St Univ Of Nj New Brunswick · R37 · FY2005 · AI
B cell determinants of EBV latency
$827,246Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2025 · CA
Mid Southern Primary Care Networks Node
$827,206Li-Tzy T Wu · Duke University · UG1 · FY2015 · DA
Targeting GI Epithelial Integrity to Improve Arterial Inflammation in HIV
$827,188Janet Lo · Massachusetts General Hospital · R01 · FY2014 · HL
Targeting GI Epithelial Integrity to Improve Arterial Inflammation in HIV
$827,188Janet Lo · Massachusetts General Hospital · R01 · FY2018 · HL
A unified intervention for young gay and bisexual men's minority stress, mental health, and HIV risk
$827,134John Edward Pachankis · Yale University · R01 · FY2016 · MH
Sample Collection and General Screening Protocols
$827,127Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Immune Dysfunction in HIV+ Opioid Users
$827,056Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · DA
Leveraging public health genotyping databases for near real-time HIV surveillance
$827,046Thomas K. Leitner · Triad National Security, Llc · R01 · FY2021 · AI
Leveraging public health genotyping databases for near real-time HIV surveillance
$827,036Thomas K. Leitner · Triad National Security, Llc · R01 · FY2022 · AI